Matrix metalloproteinases and periodontal diseases

Oral Diseases

Volumn 20, Issue 6, 2014, Pages 538-550

  Sapna, G ^a   Gokul, S ^b   Bagri Manjrekar, K ^b  

^a NAIR HOSPITAL DENTAL COLLEGE   (India)

^b YMT Dental College and Hospital   (India)

Author keywords

Matrix metalloproteinases; Periodontal diseases; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGENASE; GELATINASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE;

DISEASE ASSOCIATION; HUMAN; MEMBRANE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PERIODONTAL DISEASE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; REVIEW; ENZYMOLOGY; METABOLISM; PERIODONTAL DISEASES;

COLLAGENASES; GELATINASES; HUMANS; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; PERIODONTAL DISEASES; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84906791340     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12159     Document Type: Review

References (54)

1. Acharya MR, Venitz J, Figg WD, Sparreboom A (2004). Chemically modified tetracyclines as inhibitors of matrix metalloproteinases. Drug Resist Updat 7: 195-208.
2. Alkalin FA, Toklu E, Renda N (2005). Analysis of superoxide dismutase activity levels in the gingiva and gingival crevicular fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Periodontol 32: 238-243.
3. Amalinei C, Caruntu ID, Ginsca SE, Balan RA (2010). Matrix metalloproteinase involvement in pathological condition. Rom J Morphol Embryol 52: 215-228.
4. Ashley RA (1999). Clinical trials of a matrix metalloproteinase inhibitor in human periodontal disease. SDD clinical research team. Ann NY Acad Sci 878: 335-346.
5. Birkedal-Hansen H (1993). Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 64: 474-484.
6. Caron C, Xue J, Sun X, Simmer JP, Barlett JD (2001). Gelatinase A (MMP-2) in developing tooth tissues and amelogenin hydrolysis. J Dent Res 80: 1660-1664.
7. Costa PP, Trevisan GL, Macedo GO et al (2010). Salivary interleukin-6, matrix metalloproteinase-8 and osteoprotegerin in patients with periodontitis and diabetes. J Periodontol 81: 384-391.
8. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM (1993). Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol Ther 59: 329-341.
9. Folgueras AR, Pendas AM, Sanchez LM, Lopez- Otin L (2004). Matrix metalloproteinase in cancer: from new function to improved inhibition strategies. Int J Dev Biol 48: 411-424.
10. Gendron R, Granier D, Sorsa T, Mayrand D (1999). Inhibition of the activities of matrix metalloproteinases 2, 8 & 9 by chlorhexidine. Clin Diagn Lab Immunol 6: 437-439.
11. Golub LM, McNamara TF, D' Angelo G, Greenwald RA, Ramamurthy NS (1987). A non-antibacterial chemically modified tetracycline inhibits mammalian collagenase activity. J Dent Res 66: 1310-1314.
12. Gursoy UK, Könönen E, Huumonen S et al (2013). Salivary type I collagen degradation end-products and related matrix metalloproteinases in periodontitis. J Clin Periodontol 40: 18-25.
13. Gursoy UK, Kononen E, Pradhan-Palikhe P et al (2010). Salivary MMP-8, TIMP-1 and ICTP as markers of advanced periodontitis. J Clin Periodontol 37: 487-493.
14. Gusman H, Santana RB, Zehnder M (2002). Matrix metalloproteinase levels and gelatinolytic activity in clinically healthy and inflamed human dental pulps. Eur J Oral Sci 110: 353-357.
15. Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L (2007). The role of matrix metalloproteinases in the oral environment. Acta Odontol Scand 65: 1-13.
16. Hardy DC, Ross JH, Schuyler CA, Leite RS, Slate EH, Huang Y (2012). Matrix metalloproteinase-8 expression in periodontal tissues surgically removed from diabetic and non-diabetic patients with periodontal disease. J Clin Periodontol 39: 249-255.
17. Hernandez RM, Sorsa T, Obregon F et al (2009). Proteolytic attack of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence of MMP-13/MMP-9 activation cascade. J Clin Periodontol 36: 1011-1017.
18. Hernandez M, Gamonal J, Tervahartiala T et al (2010). Associations between MMP-8 & -14 and myeloperoxidase in gingival crevicular fluid from subjects with progressive chronic periodontitis- A longitudinal study. J Periodontol 81: 1644-1652.
19. Honibald EN, Mathew S, Padmanabhan J, Sundaram E, Ramamoorthy RK (2012). Perioceutics: matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease. J Pharm Bioallied Sci 4: 417-421.
20. Huo N, Ichikawa Y, Kamiyana M et al (2002). MMP- 7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 177: 95-100.
21. Impola U, Uitto VJ, Hietanen J et al (2004). Differential expression of matrilysin-1 (MMP-7), 92KD gelatinase (MMP-9) & metalloelastase (MMP-12) in oral verrucous and squamous cell carcinoma. J Pathol 202: 14-22.
22. Ingman T, Sorsa T, Michaelis J, Konttinen YT (1994). Matrix metalloproteinases-1, -3 and -8 in adult periodontitis in situ: an immunohistochemical study. Ann NY Acad Sci 732: 459-461.
23. Johansson N, Airola K, Grenman R, Kariniemi A-L, Saarialho- Kere U, Kahari V-M (1997). Expression of collagenase-3 (matrix metalloproteinase 13) in squamous cell carcinoma of head and neck. Am J Pathol 151: 499-508.
24. Kim JB, Jung MH, Cho J-Y, Park J-W, Sun J-Y, Lee J-M (2011). The influence of type -2 diabetes on the expression of inflammatory mediators and tissue inhibitor of metalloproteinase-2 in human chronic periodontitis. J Periodontal Implant Sci 41: 109-116.
25. Kinane DF, Darby IB, Said S et al (2003). Changes in gingival crevicular fluid and matrix metalloproteinase-8 levels during periodontal treatment and maintenance. J Periodontal Res 38: 400-404.
26. Konopka L, Pietrzak A, Brzezinska-Blaszczyk E (2012). Effect of scaling and root planing on interleukin -1β, interleukin-8 and MMP-8 levels in gingival crevicular fluid from chronic periodontitis patients. J Periodontol Res 47: 681-688.
27. Korostoff JM, Wang JF, Sarment DP, Stewart JC, Feldman RS, Billings PC (2000). Analysis of in-situ protease activity in chronic adult periodontitis patients: expression of activated MMP-2 and a 40 kDa serine protease. J Periodontol 71: 353-360.
28. Kusukava J, Sasaguri Y, Morimatsu M, Kameyama T (1995). Expression of MMP-3 in stage I and II squamous cell carcinoma of oral cavity. J Oral Maxillofac Surg 3: 530-534.
29. Lepilahti JM, Ahonen M-M, Hernandez M et al (2011). Oral rinse MMP-8 point of care immuno test identifies patents with strong periodontal inflammatory burden. Oral Dis 17: 115-122.
30. Maeso G, Bravo M, Bascones A (2007). Levels of metalloproteinase-2 & -9 and tissue inhibitor of matrix metalloproteinase-1 in gingival crevicular fluid of patients with periodontitis, gingivitis and healthy gingival. Quintessence Int 38: 247-252.
31. Makela M, Salo T, Uitto VJ, Larjava H (1994). Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J Dent Res 73: 1397-1406.
32. Mantyla P, Stenman M, Kinane DF et al (2003). Gingival crevicular fluid collagenase-2 (MMP-8) test strip for chair-side monitoring of periodontitis. J Periodontal Res 38: 436-439.
33. Marcaccini AM, Novaes AB Jr, Meschiari CA et al (2009). Circulating matrix metalloproteinase-8 (MMP-8) & MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy. Clin Chim Acta 409: 117-122.
34. Marcaccini AM, Meschiari CA, Zuardi LR et al (2010). Gingival crevicular fluid levels of MMP-8, MMP-9, TIMP-2 & MPO decrease after periodontal therapy. J Clin Periodontol 37: 180-190.
35. Nagase H (1997). Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151-160.
36. Oyarzun A, Arancibia R, Hiddalgo R et al (2010). Involvement if MT1-MMP and TIMP-2 in human periodontal disease. Oral Dis 16: 388-395.
37. Ozcaka O, Bicakci N, Pussinen P, Sotsa T, Kose T, Buduneli N (2011). Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis 17: 68-76.
38. Pacheco MM, Kowalski LP, Nishimoti IN, Brentani MM (2002). Differential expression of c-Jun and c-Fos mRNAs in squamous cell carcinoma of the head and neck: associations with UPA, gelatinase B & matrilysin mRNAs. Head Neck 24: 24-32.
39. Rai B, Kharb S, Jain R, Anand SC (2008). Biomarkers of Periodontitis in oral fluids. J Oral Sci 50: 53-56.
40. Romanelli R, Mancini S, Laschinger C, Overall CM, Sodek J, McCulloch CAG (1999). Activation of neutrophil collagenase in periodontitis. Infect Immun 67: 2319-2326.
41. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG (1994). Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 94: 79-88.
42. Sato T, del Carmen Ovejero M, Hon P et al (1997). Identification of the membrane type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110: 589-596.
43. Sorsa T, Tjaderhane L, Salo T (2004). Matrix metalloproteinases in oral diseases. Oral Dis 10: 311-318.
44. Sorsa T, Tjaderhane L, Kouttinen YT et al (2006). Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 38: 306-321.
45. Teronen O, Kontinnen YT, Salo T et al (1997). Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res 76: 1529-1537.
46. Thomas GT, Lewis MP, Speight PM (1999). Matrix metalloproteinases and oral cancer. Oral Oncol 35: 227-233.
47. Tjaderhane L, Larjara H, Sorsa T, Uitto V-J, Larmas M, Sato T (1998). The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res 77: 1622-1629.
48. Uitto V-J, Cm Overall, McCulloch C (2003). Proteolytic host enzymes in gingival crevicular fluid. Periodontology 2000(31): 77-104.
49. Verma RP, Hansch C (2007). Matrix metalloproteinases (MMPs): chemical- biological functions and (Q) SARS. Bioorg Med Chem 15: 2223-2268.
50. Verstappen J, Von den Hoff JW (2006). Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease. J Dent Res 85: 1074-1084.
51. Visse R, Nagase H (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function and biochemistry. Circ Res 92: 827-839.
52. Whittaker M, Floyd CD, Brown P, Gearing AJ (1999). Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 99: 2735-2776.
53. Woesnner JF Jr (1991). Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154.
54. Yakob M, Kari K, Tervahartiala T (2012). Association of periodontal microorganisms with salivary protein and MMP-8 in gingival crevicular fluid. J Clin Periodontol 39: 256-263.